News & Events
Latest company updates, development milestones and upcoming events from BOOST Pharma
News
EVENTS, PRESS RELEASE
September 24, 2026
BOOST Pharma selected to showcase Phase III-ready BT-101 at 2026 Cell & Gene Meeting on the Mesa
BOOST Pharma has been selected as a 2026 Innovation Spotlight company at the Cell & Gene Meeting on the Mesa, where CEO Hans Schambye will present an update on BT-101 and preparations for its planned pivotal Phase III study.
Read more ›
PRESS RELEASE
March 19, 2026
Elaine Jones Appointed as Board Chair of BOOST Pharma
Elaine Jones is a seasoned life science investor, executive and board leader to support next phase of growth as BOOST Pharma advances BT-101
Read more ›
PRESS RELEASE
February 11, 2026
Hans Schambye Appointed as Chief Executive Officer of BOOST Pharma
Hans Schambye is a highly regarded biotech entrepreneur and operator with a proven record in building and leading companies from drug discovery to late-stage clinical development and pivotal value-creating milestones.
Read more ›
View all updates›
Events
EVENTS, PRESS RELEASE
September 24, 2026
BOOST Pharma selected to showcase Phase III-ready BT-101 at 2026 Cell & Gene Meeting on the Mesa
BOOST Pharma has been selected as a 2026 Innovation Spotlight company at the Cell & Gene Meeting on the Mesa, where CEO Hans Schambye will present an update on BT-101 and preparations for its planned pivotal Phase III study.
Read more ›
EVENTS
June 22, 2026
BOOST Pharma presents BT-101 at RESI San Diego 2026
BOOST Pharma CEO Hans T. Schambye presented an update on BT-101 at RESI San Diego 2026.
Read more ›
EVENTS
May 19, 2026
BOOST Pharma presents at the 3rd ATMP Mini-Symposium in Lund
BOOST Pharma Co-founder and Chief Development Officer Lilian Walther Jallow presented at the 3rd ATMP Mini-Symposium at Lund University.
Read more ›
View all updates ›